Market Data
Market Cap₹1,534.28 Cr.
52W High₹271.45
Current Price₹142.05
52W Low₹125.7
Down from 52W High47.7 %
Face Value₹10
Performance
ROCE6.33 %
ROE3.91 %
EPS (TTM)₹0.98
EPS Prev Qtr₹1.72
EPS Last Year₹0.68
EBITDA Qtr₹22.85 Cr.
Book Value₹93
Financial Health
Debt/Equity0.54
Debt/Profit14.39
Total Assets₹1,839.13 Cr.
Promoter Holding74.33 %
Earning Power3.84 %
Valuation
Stock P/E40.59
Industry P/E40.59
Price to Book1.53
Price to Sales1.3
Graham Number₹85.51
Key Metrics
Face Value
₹10
About Shalby Ltd
Healthcare · Healthcare
Shalby Ltd is listed on NSE in the Healthcare / Healthcare sector. Face value ₹10. Market cap ₹1,534.28 Cr.
Price Chart
Strengths & Weaknesses
Strengths
- The company has a healthy promoter holding of 74.33%, indicating strong control and alignment of interests.
- The company maintains a moderate debt-to-equity ratio of 0.54, suggesting manageable leverage levels.
Weaknesses
- The P/E ratio of 44.09 is relatively high, indicating that the stock may be overvalued compared to peers.
- The P/B ratio of 1.66 suggests that the market values the company at a premium to its book value.
- The ROCE of 6.33% is relatively low, indicating inefficient use of capital.
- The ROE of 3.73% is low, reflecting weaker returns generated on shareholders' equity.
- Net profit of ₹37.51 Cr is significantly lower compared to the revenue of ₹1176.23 Cr, indicating thin profit margins.
Peer Comparison
| Name | CMP | P/E | Market Cap | Div Yield | NP Qtr | Qtr Profit Var% | Sales Qtr | Qtr Sales Var% | ROCE% | Debt/Eq |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | - | 59.87 | ₹1,25,119.97 Cr | 0.23% | ₹2,172 Cr | - | ₹26,429.9 Cr | - | 22.05% | 0.6 |
| Manipal Health Enterprises Ltd | - | - | ₹98,508.6 Cr | - | - | - | - | - | - | 1.25 |
| Max Healthcare Institute Ltd | - | 65.64 | ₹95,762.32 Cr | 0.2% | ₹1,457.4 Cr | - | ₹8,712.05 Cr | - | 14.38% | 0.27 |
| Aster DM Quality Care Ltd | - | 118.98 | ₹64,094.07 Cr | 0.41% | ₹362.82 Cr | - | ₹4,876.03 Cr | - | 12.95% | 0.17 |
| Fortis Healthcare Ltd | - | 59.01 | ₹61,831.07 Cr | 0.12% | ₹1,070.21 Cr | - | ₹9,506.15 Cr | - | 13.34% | 0.29 |
| Global Health Ltd | - | 68.38 | ₹38,058.8 Cr | - | ₹552.33 Cr | - | ₹4,683.41 Cr | - | 21.87% | 0.1 |
| Narayana Hrudayalaya Ltd | - | 44.88 | ₹36,850.34 Cr | - | ₹816.55 Cr | - | ₹9,072.4 Cr | - | 13.65% | 1.07 |
| Dr Lal Pathlabs Ltd | - | 47.16 | ₹32,792.46 Cr | 1.25% | ₹546.3 Cr | - | ₹2,890.8 Cr | - | 29.55% | 0 |
| Krishna Institute of Medical Sciences Ltd | - | 151 | ₹32,344.7 Cr | - | ₹194.4 Cr | - | ₹4,212.5 Cr | - | 9.66% | 1.44 |
| Poly Medicure Ltd | - | 52.78 | ₹16,633.09 Cr | 0.21% | ₹312.92 Cr | - | ₹1,997.43 Cr | - | 15.07% | 0.06 |
| Dr Agarwals Health Care Ltd | - | 105.51 | ₹15,685.91 Cr | - | ₹185.1 Cr | - | ₹2,206.68 Cr | - | 16.46% | 0.08 |
| Vijaya Diagnostic Centre Ltd | - | 81.03 | ₹15,200.42 Cr | 0.14% | ₹187.49 Cr | - | ₹857.13 Cr | - | 36.21% | 0 |
| Syngene International Ltd | - | 66.95 | ₹14,863.1 Cr | 0.34% | ₹221 Cr | - | ₹3,600.2 Cr | - | 6.95% | 0 |
| Indegene Ltd | - | 36.18 | ₹14,568.1 Cr | 0.37% | ₹400.9 Cr | - | ₹3,812.8 Cr | - | 17.45% | 0 |
| Molbio Diagnostics Ltd | - | - | ₹14,188.59 Cr | - | - | - | - | - | - | 0.35 |
| Rainbow Childrens Medicare Ltd | - | 48.68 | ₹13,896.34 Cr | 0.26% | ₹290.28 Cr | - | ₹1,820.14 Cr | - | 27.05% | 0 |
| Park Medi World Ltd | - | 38.3 | ₹11,942.89 Cr | - | ₹296.75 Cr | - | ₹1,756.29 Cr | - | 19.17% | 0.11 |
| Metropolis Healthcare Ltd | - | 24.09 | ₹11,664.5 Cr | 0.89% | ₹202.82 Cr | - | ₹1,710 Cr | - | 19.8% | 0.01 |
| Yatharth Hospital & Trauma Care Services Ltd | - | 58.81 | ₹10,653.42 Cr | - | ₹174.45 Cr | - | ₹1,334.1 Cr | - | 11.7% | 0.14 |
| Healthcare Global Enterprises Ltd | - | 452.55 | ₹10,472.8 Cr | - | ₹33.26 Cr | - | ₹2,627.35 Cr | - | 9.41% | 0.68 |
Quarterly Results
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Sales | 285.43 | 272.13 | 287.45 | 331.22 |
| ↳ QoQ Growth | - | -4.7% | +5.6% | +15.2% |
| Expenses | 261.19 | 259.48 | 276.58 | 308.38 |
| Operating Profit | 24.24 | 12.64 | 10.87 | 22.85 |
| OPM % | 8.49% | 4.64% | 3.78% | 6.9% |
| Other Income | 4.48 | 7.23 | 8.08 | 7.41 |
| Interest | 9.65 | 10.64 | 9.34 | 10.57 |
| Depreciation | 17.37 | 17.61 | 18.49 | 18.74 |
| EBITDA | 41.61 | 30.25 | 29.36 | 41.59 |
| EBITDA Margin % | 14.58% | 11.12% | 10.21% | 12.56% |
| Profit Before Tax | 19.07 | 9.23 | 9.61 | 19.7 |
| Tax % | 61.88% | 86.13% | -92.09% | 46.7% |
| Net Profit | 7.28 | 1.28 | 18.45 | 10.5 |
| ↳ QoQ Growth | - | -82.4% | +1341.4% | -43.1% |
| EPS | 0.68 | 0.12 | 1.72 | 0.98 |
Balance Sheet
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 107.49 | 107.519 |
| Reserves | 884.7 | 897.716 |
| Borrowings | 475.93 | 539.62 |
| Other Liabilities | 235.53 | 294.28 |
| Total Liabilities | 1703.65 | 1839.13 |
| Fixed Assets | 888.33 | 1064.314 |
| CWIP | 8.04 | 0.393 |
| Investments | 94.63 | 62.26 |
| Other Assets | 712.65 | 712.16 |
| Total Assets | 1703.65 | 1839.13 |
Cash Flows
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Cash from Operating Activity | -4.343 | -0.01 |
| Cash from Investing Activity | -35.637 | -97.284 |
| Cash from Financing Activity | 47.584 | 84.411 |
| Net Cash Flow | 7.604 | -12.883 |
Shareholding Pattern
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Promoters % | 74.33% | 74.33% | 74.33% | 74.33% |
| FIIs % | 4.64% | 4.47% | 4.36% | 4.46% |
| DIIs % | 0.19% | 0.19% | 0.25% | 0.3% |
| Public % | 11.74% | 11.73% | 11.52% | 12.12% |
| No. of Shareholders | 53,784 | 52,495 | 51,415 | 50,770 |
Major Shareholders (>1%)
- Shah Family Trust Throuh Dr. Vikram Shah, TrusteePromoter and Promoter Group34.79%
- Zodiac Mediquip LimitedPromoter and Promoter Group29.21%
- Vikram Indrajit ShahPromoter and Promoter Group7.41%
- Darshini Vikram ShahPromoter and Promoter Group2.79%
As of 2026-06-30View all shareholders →